TPO and myeloid sarcoma: We found no significantly different rates of abnormal Anti‐TPO in MS patients (Table 1) and males and females did not differ in any of the anti‐thyroid antibodies in our study (Tables 2, 3) which differs from the findings of Annunziata et al. These diverse results could be affected by several factors.